Streamlining Recommendations for Topical and Mucosal ProductsBack to: Advancing Generic Drug Development 2025 Previous LessonProduct-Specific Guidance Revisions: Update on Metered Dose Inhaler & Dry Powder InhalerLesson 3 within section Session 1: Insights to Product-Specific Guidance for Complex Products: From Research to Standards. Next LessonSession 1: Q&A Panel (Advancing Generic Drug Development 2025)Lesson 5 within section Session 1: Insights to Product-Specific Guidance for Complex Products: From Research to Standards. You must enroll in this course to access course content. Presenter Megan Kelchen, PhDSenior PharmacologistDTPI | ORS | OGD | CDER | FDA Leave a Comment Cancel replyLogin with your Social IDYour email address will not be published. Required fields are marked *Name * Email * Website Comment * Save my name, email, and website in this browser for the next time I comment. Δ